Nolan Traore: Everything you need to know

Nolan Traore

#88 PG

Brooklyn Nets

Status

OUT - Illness - Not Specified Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

8.9

1.8

3.8

0.4

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	56	31	22.2	8.9	1.8	3.8	0.4	0.8	2.3	1	0	1.1	3.4	31.8%	2.2	5.1	42.2%	3.3	8.6	38.0%	1.3	1.7	78.7%	0.3	1.5	2.1	1.7	-280	47.9%
Career	56	31	22.2	8.9	1.8	3.8	0.4	0.8	2.3	1	0	1.1	3.4	31.8%	2.2	5.1	42.2%	3.3	8.6	38.0%	1.3	1.7	78.7%	0.3	1.5	2.1	1.7	-280	47.9%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/12	PHX	W 111-109	17	4	2	3	0	0	4	2	0	0.0%	3	2	66.7%	5	2	40.0%	0	0	0.0%	0	2	0.8	-3	3	2	40.0%
10/10	PHX	L 132-127	17	6	1	1	0	0	4	1	0	0.0%	4	3	75.0%	5	3	60.0%	0	0	0.0%	0	1	0.3	+12	2	1	60.0%
10/4	HAP	W 123-88	18	7	2	2	0	0	1	3	1	33.3%	3	1	33.3%	6	2	33.3%	2	2	100.0%	0	2	2.0	+10	0	7	50.9%
Preseason Totals			17.5	5.7	1.7	2.0	0.0	0.0	3.0	2.0	0.3	16.7%	3.3	2.0	60.0%	5.3	2.3	43.8%	0.7	0.7	100.0%	0.0	1.7	0.7	+19	1.7	3.7	50.4%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/7	MIL	W 96-90	9	5	1	2	1	1	2	1	1	100.0%	1	1	100.0%	2	2	100.0%	0	0	0.0%	0	1	1.0	+13	0	8	125.0%
4/5	WAS	W 121-115	28	23	2	7	0	0	3	11	5	45.5%	7	2	28.6%	18	7	38.9%	4	4	100.0%	0	2	2.3	+6	0	20	58.2%
4/3	ATL	L 141-107	29	13	2	4	1	3	2	6	2	33.3%	5	3	60.0%	11	5	45.5%	2	1	50.0%	0	2	2.0	-23	4	11	54.7%
3/31	CHA	L 117-86	22	10	5	4	0	0	4	2	0	0.0%	6	4	66.7%	8	4	50.0%	2	2	100.0%	0	5	1.0	-9	3	9	56.3%
3/29	SAC	W 116-99	29	17	3	6	0	1	4	9	2	22.2%	4	4	100.0%	13	6	46.2%	5	3	60.0%	0	3	1.5	+10	4	13	55.9%
3/27	LAL	L 116-99	25	9	1	7	0	4	6	4	1	25.0%	10	3	30.0%	14	4	28.6%	0	0	0.0%	0	1	1.2	-11	4	2	32.1%
3/23	POR	L 134-99	16	0	3	5	1	1	2	4	0	0.0%	5	0	0.0%	9	0	0.0%	0	0	0.0%	0	3	2.5	-14	2	4	0.0%
3/22	SAC	L 126-122	26	17	2	4	0	1	2	5	2	40.0%	7	4	57.1%	12	6	50.0%	3	3	100.0%	0	2	2.0	-1	2	17	63.8%
3/20	NYK	L 93-92	23	11	2	7	2	1	4	3	1	33.3%	8	2	25.0%	11	3	27.3%	4	4	100.0%	0	2	1.8	-2	6	7	43.1%
3/18	OKC	L 121-92	26	13	3	6	2	1	6	5	2	40.0%	9	2	22.2%	14	4	28.6%	4	3	75.0%	0	3	1.0	-9	2	9	41.2%
3/16	POR	L 114-95	16	4	1	1	0	1	0	2	0	0.0%	6	1	16.7%	8	1	12.5%	4	2	50.0%	0	1	0.0	-19	0	1	20.5%
3/14	PHI	L 104-97	17	6	1	3	0	0	5	6	2	33.3%	4	0	0.0%	10	2	20.0%	0	0	0.0%	0	1	0.6	-21	3	7	30.0%
3/10	DET	L 138-100	15	2	2	2	0	0	2	2	0	0.0%	4	1	25.0%	6	1	16.7%	0	0	0.0%	1	1	1.0	-19	2	3	16.7%
3/9	MEM	W 126-115	23	17	1	4	1	0	1	5	4	80.0%	4	2	50.0%	9	6	66.7%	2	1	50.0%	0	1	4.0	+11	1	18	86.0%
3/7	DET	W 107-105	15	2	1	2	1	1	4	0	0	0.0%	5	1	20.0%	5	1	20.0%	0	0	0.0%	0	1	0.5	-13	4	6	20.0%
3/5	MIA	L 126-110	24	9	3	9	0	0	3	2	1	50.0%	7	3	42.9%	9	4	44.4%	0	0	0.0%	2	1	3.0	-4	1	11	50.0%
3/3	MIA	L 124-98	22	14	2	0	0	0	6	4	2	50.0%	8	3	37.5%	12	5	41.7%	2	2	100.0%	0	2	0.0	-23	2	0	54.3%
3/1	CLE	L 106-102	29	17	1	2	0	1	3	6	1	16.7%	9	6	66.7%	15	7	46.7%	2	2	100.0%	0	1	0.7	-2	4	7	53.5%
2/27	BOS	L 148-111	24	8	2	7	0	3	2	2	0	0.0%	7	4	57.1%	9	4	44.4%	0	0	0.0%	0	2	3.5	-19	1	11	44.4%
2/26	SAS	L 126-110	29	13	2	3	0	0	1	2	1	50.0%	12	4	33.3%	14	5	35.7%	2	2	100.0%	1	1	3.0	-8	3	6	43.7%
2/24	DAL	L 123-114	27	8	3	6	1	3	3	3	0	0.0%	8	4	50.0%	11	4	36.4%	0	0	0.0%	1	2	2.0	+2	5	5	36.4%
2/22	ATL	L 115-104	34	11	1	5	0	2	5	3	1	33.3%	11	3	27.3%	14	4	28.6%	4	2	50.0%	1	0	1.0	+7	2	2	34.9%
2/20	OKC	L 105-86	26	17	1	3	1	2	4	4	1	25.0%	7	4	57.1%	11	5	45.5%	6	6	100.0%	0	1	0.8	-6	0	17	62.3%
2/19	CLE	L 112-84	30	8	1	5	0	2	4	3	1	33.3%	8	2	25.0%	11	3	27.3%	2	1	50.0%	0	1	1.3	-19	2	2	33.7%
2/11	IND	L 115-110	31	20	2	8	0	1	5	3	2	66.7%	10	6	60.0%	13	8	61.5%	4	2	50.0%	0	2	1.6	+12	5	14	67.8%
2/9	CHI	W 123-115	31	13	3	13	1	1	3	2	0	0.0%	9	5	55.6%	11	5	45.5%	4	3	75.0%	1	2	4.3	+17	4	19	50.9%
2/7	WAS	W 127-113	23	15	3	4	0	0	1	3	2	66.7%	4	4	100.0%	7	6	85.7%	1	1	100.0%	0	3	4.0	-18	5	19	100.8%
2/5	ORL	L 118-98	37	21	3	7	0	1	4	7	3	42.9%	6	4	66.7%	13	7	53.8%	5	4	80.0%	1	2	1.8	-11	3	20	69.1%
2/3	LAL	L 125-109	24	7	5	4	0	0	2	3	1	33.3%	6	2	33.3%	9	3	33.3%	0	0	0.0%	2	3	2.0	-4	1	7	38.9%
2/1	DET	L 130-77	17	5	1	2	1	0	4	3	1	33.3%	4	1	25.0%	7	2	28.6%	0	0	0.0%	0	1	0.5	-18	3	3	35.7%
1/30	UTA	W 109-99	25	7	2	6	2	0	1	2	0	0.0%	6	3	50.0%	8	3	37.5%	1	1	100.0%	0	2	6.0	-9	1	10	41.5%
1/29	DEN	L 107-103	30	9	2	4	1	0	0	1	0	0.0%	6	4	66.7%	7	4	57.1%	2	1	50.0%	0	2	0.0	+4	2	11	57.1%
1/23	BOS	L 130-126	36	21	3	2	1	2	2	4	2	50.0%	9	5	55.6%	13	7	53.8%	6	5	83.3%	0	3	1.0	+8	3	19	67.1%
1/21	NYK	L 120-66	18	0	1	3	0	0	3	1	0	0.0%	2	0	0.0%	3	0	0.0%	0	0	0.0%	0	1	1.0	-20	3	7	0.0%
1/19	PHX	L 126-117	22	10	1	2	0	0	0	3	1	33.3%	5	2	40.0%	8	3	37.5%	3	3	100.0%	0	1	0.0	+4	0	10	53.6%
1/18	CHI	L 124-102	26	16	1	2	0	0	1	5	4	80.0%	3	0	0.0%	8	4	50.0%	6	4	66.7%	1	0	2.0	-10	1	13	75.2%
1/16	CHI	W 112-109	27	8	2	7	0	1	2	4	2	50.0%	3	0	0.0%	7	2	28.6%	2	2	100.0%	0	2	3.5	-12	4	7	50.8%
1/14	NOP	L 116-113	19	5	1	1	0	0	2	5	1	20.0%	3	1	33.3%	8	2	25.0%	0	0	0.0%	0	1	0.5	-5	3	4	31.3%
1/12	DAL	L 113-105	21	6	1	6	0	1	3	4	0	0.0%	5	3	60.0%	9	3	33.3%	0	0	0.0%	1	0	2.0	-10	0	6	33.3%
1/11	MEM	L 103-98	19	4	0	6	0	0	0	5	0	0.0%	4	2	50.0%	9	2	22.2%	0	0	0.0%	0	0	0.0	+11	3	0	22.2%
1/9	LAC	L 121-105	21	5	2	3	0	0	1	1	1	100.0%	6	1	16.7%	7	2	28.6%	0	0	0.0%	0	2	3.0	-9	1	2	35.7%
1/7	ORL	L 104-103	20	6	3	2	1	1	1	5	2	40.0%	0	0	0.0%	5	2	40.0%	0	0	0.0%	0	3	2.0	-8	2	8	60.0%
1/4	DEN	W 127-115	18	5	3	4	0	0	2	7	1	14.3%	3	1	33.3%	10	2	20.0%	0	0	0.0%	0	3	2.0	-4	0	2	25.0%
1/2	WAS	L 119-99	25	12	1	5	2	1	2	0	0	0.0%	7	4	57.1%	7	4	57.1%	4	4	100.0%	0	1	2.5	-5	1	18	68.5%
1/1	HOU	L 120-96	26	3	0	2	0	1	2	5	1	20.0%	3	0	0.0%	8	1	12.5%	0	0	0.0%	0	0	1.0	+0	2	5	18.8%
12/29	GSW	L 120-107	14	9	0	0	1	0	2	4	3	75.0%	2	0	0.0%	6	3	50.0%	0	0	0.0%	0	0	0.0	-21	3	2	75.0%
12/27	MIN	W 123-107	18	4	1	4	0	1	1	0	0	0.0%	2	2	100.0%	2	2	100.0%	0	0	0.0%	0	1	4.0	+17	2	8	100.0%
12/23	PHI	W 114-106	14	5	1	2	0	0	3	1	0	0.0%	2	2	100.0%	3	2	66.7%	1	1	100.0%	0	1	0.7	+3	2	2	72.7%
12/21	TOR	W 96-81	22	8	3	2	1	1	1	4	1	25.0%	5	2	40.0%	9	3	33.3%	2	1	50.0%	0	3	2.0	-7	1	6	40.5%
12/14	MIL	W 127-82	9	0	2	3	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	2	0.0	+13	0	4	0.0%
12/12	DAL	L 119-111	8	0	1	0	0	0	0	1	0	0.0%	1	0	0.0%	2	0	0.0%	0	0	0.0%	1	0	0.0	-5	2	4	0.0%
11/18	BOS	L 113-99	1	0	0	1	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	-2	0	1	0.0%
11/3	MIN	L 125-109	3	0	0	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+1	0	1	0.0%
10/27	HOU	L 137-109	20	4	1	3	0	0	2	3	1	33.3%	2	0	0.0%	5	1	20.0%	2	1	50.0%	0	1	1.5	-14	4	2	34.0%
10/22	CHA	L 136-117	8	3	0	1	0	2	0	2	1	50.0%	1	0	0.0%	3	1	33.3%	0	0	0.0%	0	0	0.0	-8	1	3	50.0%
Regular Season Totals			22.3	8.8	1.7	3.9	0.4	0.8	2.3	3.3	1.1	32.8%	5.1	2.1	41.5%	8.5	3.2	38.1%	1.7	1.3	78.0%	0.2	1.5	1.7	-283	2.2	9.0	48.0%

Nolan Traore: Breaking News

Traore (illness) has been ruled out for Sunday's game against the Raptors. The rookie first-rounder is under the weather and will miss Brooklyn's regular-season finale. Traore saw limited action early in the campaign but eventually earned a more sizable role, and he'll finish the season with averages of 8.9 points, 3.8 assists and 1.8 rebounds while shooting 38.0 percent from the field in 22.2 minutes per showing across 56 regular-season games (31 starts).

Traore (illness) has been downgraded from questionable to doubtful for Sunday's game against the Raptors. It looks like Traore will not be available for Sunday's regular-season finale while battling through an illness. Tyson Etienne, Malachi Smith and Drake Powell should all see an uptick in playing time if Traore is indeed ruled out.

Traore is questionable to play Sunday in Toronto due to an illness, Erik Slater of ClutchPoints.com reports. If Traore can't give it a go Sunday, Drake Powell would likely pick up most of his minutes. Check back for official word on Traore closer to Sunday's tipoff.